Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 24 12:23PM ET
0.9000
Dollar change
+0.0200
Percentage change
2.27
%
Index- P/E- EPS (ttm)-0.81 Insider Own33.99% Shs Outstand14.78M Perf Week37.40%
Market Cap13.30M Forward P/E- EPS next Y-0.40 Insider Trans-4.37% Shs Float9.76M Perf Month0.00%
Income-12.36M PEG- EPS next Q-0.12 Inst Own4.20% Short Float0.42% Perf Quarter-12.62%
Sales0.00M P/S- EPS this Y3.13% Inst Trans- Short Ratio0.06 Perf Half Y-71.83%
Book/sh0.21 P/B4.21 EPS next Y35.48% ROA-587.64% Short Interest0.04M Perf Year-
Cash/sh0.24 P/C3.77 EPS next 5Y- ROE-1807.80% 52W Range0.63 - 7.98 Perf YTD-14.29%
Dividend Est.- P/FCF- EPS past 5Y- ROI-391.51% 52W High-88.72% Beta-
Dividend TTM- Quick Ratio5.70 Sales past 5Y0.00% Gross Margin- 52W Low42.65% ATR (14)0.11
Dividend Ex-Date- Current Ratio5.70 EPS Y/Y TTM- Oper. Margin0.00% RSI (14)54.63 Volatility27.82% 13.05%
Employees3 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom- Target Price-
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q4.18% Payout- Rel Volume0.19 Prev Close0.88
Sales Surprise- EPS Surprise5.88% Sales Q/Q- Earnings- Avg Volume647.55K Price0.90
SMA2013.78% SMA50-3.44% SMA200-61.48% Trades Volume57,388 Change2.27%
May-21-24 08:45AM
May-20-24 08:00AM
May-13-24 09:53PM
Apr-02-24 08:00AM
Apr-01-24 02:53PM
11:04AM Loading…
Mar-21-24 11:04AM
Mar-08-24 08:19AM
Feb-05-24 08:30AM
Dec-04-23 08:00AM
Nov-29-23 08:00AM
Nov-21-23 10:42AM
10:09AM
Nov-20-23 08:00AM
Oct-26-23 07:23AM
Sep-18-23 08:30AM
08:31AM Loading…
Sep-05-23 08:31AM
Aug-31-23 08:31AM
Aug-29-23 11:39AM
Aug-09-23 09:35AM
Aug-03-23 02:40PM
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company engages in developing its product candidate, MIRA1a, as a synthetic cannabinoid analog for treating anxiety & chronic pain by targeting the cannabinoid type 1 and type 2 (CB1 and CB2) receptors. MIRA Pharmaceuticals was founded by Adam Kaplin on September 3, 2020 and is headquartered in Miami, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Aminov ErezChief Executive OfficerMay 21 '24Buy0.948,7008,176382,200May 22 05:42 PM
McNulty Brian Patrick10% OwnerDec 11 '23Sale1.5546,00571,496660,000Dec 27 05:33 PM
McNulty Brian Patrick10% OwnerDec 08 '23Sale1.6119,05330,633683,002Dec 27 05:33 PM
McNulty Brian Patrick10% OwnerDec 07 '23Sale1.8933,33363,156692,529Dec 27 05:33 PM
McNulty Brian Patrick10% OwnerDec 06 '23Sale2.9527,73381,785709,196Dec 27 05:33 PM
McNulty Brian Patrick10% OwnerDec 04 '23Sale3.9861,331244,097723,062Dec 27 05:33 PM
McNulty Brian Patrick10% OwnerNov 30 '23Sale3.774,84218,273753,728Dec 27 05:33 PM
McNulty Brian Patrick10% OwnerNov 29 '23Sale3.987,39929,445756,149Dec 27 05:33 PM
McNulty Brian Patrick10% OwnerNov 28 '23Sale4.00241964759,849Dec 27 05:33 PM
McNulty Brian Patrick10% OwnerNov 27 '23Sale4.006,42525,715759,969Dec 27 05:33 PM
McNulty Brian Patrick10% OwnerNov 21 '23Sale5.005,00025,000763,181Dec 27 05:33 PM
McNulty Brian Patrick10% OwnerNov 20 '23Sale5.0726,733135,523765,681Dec 27 05:33 PM
Cappy George10% OwnerAug 07 '23Buy7.00119,048833,3362,859,318Aug 24 05:38 PM
Cappy George10% OwnerAug 02 '23Buy7.00157,1701,100,1902,740,270Aug 04 01:42 PM